Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shreyas Joshi

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Clinical Oral Investigations|April 28, 2015
Prognostic role of Oct4, CD44 and c-Myc in radio-chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient miceSharada Sawant, Ravindran Gokulan, Harsh Dongre, et al.
JCO Precision Oncology|August 20, 2025
Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United StatesJames R Janopaul-Naylor, Dattatraya Patil, Shreyas Joshi, et al.
Clinical Genitourinary Cancer|February 14, 2021
Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer DatabaseKaren M Xu, Yuan Liu, Theresa W Gillespie, et al.
Communications Biology|March 22, 2021
Author Correction: Immunoreactive peptide maps of SARS-CoV-2 and other human coronavirusesNischay Mishra, Xi Huang, Shreyas Joshi, et al.
Communications Biology|February 13, 2021
Immunoreactive peptide maps of SARS-CoV-2Nischay Mishra, Xi Huang, Shreyas Joshi, et al.
BJU International|November 1, 2024
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
European Urology Open Science|February 12, 2025
Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical CystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
JAMA Dermatology|February 9, 2022
Human Polyomavirus 9-An Emerging Cutaneous and Pulmonary Pathogen in Solid Organ Transplant RecipientsNischay Mishra, James Ng, Mark A Strom, et al.
The Oncologist|January 6, 2026
An Increase in Splenic Volume After First-Line Immunotherapy is Associated with Worse PFS in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Ahmet Yildirim, Taylor Goodstein, et al.
Immunity|December 29, 2022
CD8<sup>+</sup> T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumorNataliya Prokhnevska, Maria A Cardenas, Rajesh M Valanparambil, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Clinical Oral Investigations|April 28, 2015
Prognostic role of Oct4, CD44 and c-Myc in radio-chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient miceSharada Sawant, Ravindran Gokulan, Harsh Dongre, et al.
JCO Precision Oncology|August 20, 2025
Sociodemographic Features, Health Care Costs, and Treatment Implications of Genomic Classifier Testing for Localized Prostate Cancer in the United StatesJames R Janopaul-Naylor, Dattatraya Patil, Shreyas Joshi, et al.
Clinical Genitourinary Cancer|February 14, 2021
Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer DatabaseKaren M Xu, Yuan Liu, Theresa W Gillespie, et al.
Communications Biology|March 22, 2021
Author Correction: Immunoreactive peptide maps of SARS-CoV-2 and other human coronavirusesNischay Mishra, Xi Huang, Shreyas Joshi, et al.
Communications Biology|February 13, 2021
Immunoreactive peptide maps of SARS-CoV-2Nischay Mishra, Xi Huang, Shreyas Joshi, et al.
BJU International|November 1, 2024
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
European Urology Open Science|February 12, 2025
Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical CystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
JAMA Dermatology|February 9, 2022
Human Polyomavirus 9-An Emerging Cutaneous and Pulmonary Pathogen in Solid Organ Transplant RecipientsNischay Mishra, James Ng, Mark A Strom, et al.
The Oncologist|January 6, 2026
An Increase in Splenic Volume After First-Line Immunotherapy is Associated with Worse PFS in Patients with Metastatic Renal Cell CarcinomaGregory Palmateer, Ahmet Yildirim, Taylor Goodstein, et al.
Immunity|December 29, 2022
CD8<sup>+</sup> T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumorNataliya Prokhnevska, Maria A Cardenas, Rajesh M Valanparambil, et al.
Pageof 4